Sven Olek

8.4k citations

77 papers · 6.2k indexed · 3 hit papers · h-index 36

Impact in

Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
Transplantation top 2%

Papers in

Immunology 53
- Immune Cell Function and Interaction 40
- T-cell and B-cell Immunology 38
- Immunotherapy and Immune Responses 10
Transplantation 5
- Renal Transplantation Outcomes and Treatments 5

Co-authors: Jochen Huehn Udo Baron Stefan Floess Alf Hamann Julia K. Polansky Jennifer Freyer Georg Wieczorek Karsten Kretschmer
Journals: PLoS ONE (7 papers)European Journal of Immunology (5 papers)Blood (4 papers)The Journal of Immunology (3 papers)Allergy (3 papers)
Partner nations: Germany United States Italy

In The Last Decade

Sven Olek

76 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

DNA methylation controls Foxp3 gene expression 2008 · 615 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 European Journal of Immunology
2007 European Journal of Immunology
2007 PLoS Biology

Peers

Countries citing papers authored by Sven Olek

Since Specialization

Citations

This map shows the geographic impact of Sven Olek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Olek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Olek more than expected).

Fields of papers citing papers by Sven Olek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Olek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Olek. The network helps show where Sven Olek may publish in the future.

Co-authors

The 25 scholars most cited alongside Sven Olek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sven Olek Line = papers co-authored together Sven Olek links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome Journal of Clinical Immunology ·Rebecca C. Wyatt, Sven Olek, Elisa De Franco, 汪洪梅, Kashyap Patel, Jayne Houghton, Steffi Walter, Ronald S. Hafner, Rosa Bacchetta, Andrew T. Hattersley, Sarah E. Flanagan, Matthew B. Johnson	2023	8
2	Epigenetic immune monitoring for COVID-19 disease course prognosis Frontiers in Immunology ·Vladislav Erofeev, Scarlat G. R. Anjos, Tatyana A. Nagornaya, Tatiana M. Ovalle, J.N. Pouwelse, Laura Lozza, 和子岩本, Dorcas Joseph, Nina Babel, Sven Olek	2023	4
3	Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study Transplant International ·Arturo Blazquez‐Navarro, Chantip Dang‐Heine, Maryam Galavi, Toralf Roch, Chris Bauer, Park Tae Hyung, Tzu-Ling Huang, Kinkichi Kurihara, Kerstin Wolk, Robert Sabat, Timm H. Westhoff, Sven Olek, Oliver Thomusch, Harald Seitz, Petra Reinke, Christian Hugo, Birgit Sawitzki, Michal Or‐Guil, Nina Babel	2021	7
4	Human LAP⁺GARP⁺FOXP3⁺ regulatory T cells attenuate xenogeneic graft versus host disease Theranostics ·Huihui Wang, 正和明石, Takano Keiichi, Laurence J.N. Cooper, Rosenquist Be, Sven Olek, Dat Q. Tran	2019	8
5	Age dependent differences in the kinetics of γδ T cells after influenza vaccination PLoS ONE ·Ulrik Stervbo, Dominika Pohlmann, Udo Baron, Cecilia Bozzetti, Karsten Jürchott, Stephanie Saunders Peshek, Mikalai Nienen, Sven Olek, Toralf Roch, Axel Schulz, Sarah Warth, Avidan U. Neumann, Andreas Thiel, Andreas Grützkau, Nina Babel	2017	17
6	Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions Experimental Hematology ·Sarvari Velaga, Christina Alter, Ulrike Dringenberg, Agnieszka Nobis, Yadollah Royaï, Sven Olek, Sya N. Ukena, Anke Franzke	2016	12
7	Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium Tumor Biology ·Rosita Capone, Ilary Ruscito, Sven Olek, Rolf Richter, Lotika Singh, Ivana Türbachova, Hannah Woopen, Udo Baron, Elena Ioana Braicu, Jalid Sehouli	2016	13
8	Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination PLoS ONE ·Karsten Jürchott, Axel Schulz, Cecilia Bozzetti, Dominika Pohlmann, Ulrik Stervbo, Sarah Warth, Stephanie Saunders Peshek, Britt Garwood, Brunhilde Schweiger, Sven Olek, Andreas Grützkau, Nina Babel, Andreas Thiel, Avidan U. Neumann	2016	12
9	Foxp3 ⁺ regulatory T cells are expanded in severe atopic dermatitis patients Allergy ·Lennart M. Roesner, Stefan Floess, T Witte, Sven Olek, Jochen Huehn, Thomas Werfel	2015	44
10	Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg JNCI Journal of the National Cancer Institute ·Sebastian Barth, Rosenquist Be, Tilman Kühn, 良湯上, Anika Hüsing, Theron Johnson, Rudolf Kaaks, Sven Olek	2015	24
11	Effects of aging on human leukocytes (part I): immunophenotyping of innate immune cells AGE ·Ulrik Stervbo, ALKAN Feray DAĞALP, Stephanie Saunders Peshek, Udo Baron, Cecilia Bozzetti, Karsten Jürchott, Mikalai Nienen, Sven Olek, B. Fatima, Axel Schulz, Britt Garwood, Avidan U. Neumann, Nina Babel, Andreas Grützkau, Andreas Thiel	2015	39
12	Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms Journal of Hepatology ·Marcial Sebode, Moritz Peiseler, Meghana R. Sagar, Dorothee Schwinge, Tanja Schoknecht, n Brow, Alexander Quaas, Britt‐Sabina Petersen, Eva Ellinghaus, Udo Baron, Sven Olek, Christiane Wiegard, Christina Weiler‐Normann, Ansgar W. Lohse, Johannes Herkel, Christoph Schramm	2014	84
13	Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response Allergy Asthma and Clinical Immunology ·Amrit Singh, Masatsugu Yamamoto, Jian Ruan, ANDREA MOMBELI, Gail M. Gauvreau, Sven Olek, Yong Ding, Christopher Carlsten, J. Mark FitzGerald, Louis‐Philippe Boulet, Paul M. O’Byrne, Scott J. Tebbutt	2014	24
14	Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies Journal of Hepatology ·Richard Taubert, Matthias Hardtke‐Wolenski, Fatih Noyan, U. Borgmann, Anna Baumann, Jérôme Schlué, Sven Olek, Christine S. Falk, Michael P. Manns, Elmar Jaeckel	2014	113
15	An optimized multi-parameter flow cytometry protocol for human T regulatory cell analysis on fresh and viably frozen cells, correlation with epigenetic analysis, and comparison of cord and adult blood Journal of Immunological Methods ·S.A. Helms, Kory L. Alderson, Georgia Vullinghs, Michael D. Evans, Paul M. Sondel, Sven Olek, Christine M. Seroogy	2012	32
16	DNA Methylation Patterns Reflect Epigenetic Reprogramming in Bovine Embryos Cellular Reprogramming ·Heiner Niemann, Joseph W. Carnwath, Doris Herrmann, Georg Wieczorek, Erika Lemme, Andrea Lucas‐Hahn, Sven Olek	2010	59
17	Regulatory (FOXP3⁺) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer Cancer Science ·Christoph Loddenkemper, Suo Yunbo, Jonas Stanke, Dirk Nagorsen, Udo Baron, Sven Olek, Jochen Huehn, María José Acelga Martínez, Harald Stein, Andreas M. Kaufmann, Achim Schneider, Günter Cichon	2009	56
18	Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter Arthritis & Rheumatism ·Peter Jan Zimmermann, Stéphane Boeuf, Andrea Dickhut, Alain P. Durocher, Sven Olek, Wiltrud Richter	2008	81
19	DNA Methylation Analysis as a Tool for Cell Typing Epigenetics ·Udo Baron, Ivana Türbachova, Lotika Singh, Florian Eckhardt, Kurt Berlin, Ulrich Hoffmüller, Paul J. Gardina, Sven Olek	2006	50
20	The Adenosine Deaminase-Binding Region Is Distinct from Major Anti-CD26 mAb Epitopes on the Human Dipeptidyl Peptidase IV(CD26) Molecule Cellular Immunology ·Jochen Hühn, Sven Olek, Bernhard Fleischer, Arne von Bonin	1999	12

About Sven Olek

Sven Olek is a scholar working on Immunology, Transplantation, Reproductive Medicine, Oncology and Genetics, having authored 77 papers that have together received 6.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (40 papers), T-cell and B-cell Immunology (38 papers), Immunotherapy and Immune Responses (10 papers), Diabetes and associated disorders (7 papers), Renal Transplantation Outcomes and Treatments (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). The work is most often cited by research in Immunology (4.1k citations), Transplantation (237 citations), Immunology and Allergy (299 citations), Hepatology (358 citations) and Oncology (882 citations). Sven Olek has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Jochen Huehn, Udo Baron, Stefan Floess, Alf Hamann, Julia K. Polansky, Jennifer Freyer, Georg Wieczorek, Karsten Kretschmer, Stefan Klein-Heßling and Edgar Serfling. Their work appears in journals such as PLoS ONE, European Journal of Immunology, Blood, The Journal of Immunology and Allergy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact